Syam Sundar Neti, Bo Wang, Jiayuan Cui, David F Iwig, Nicholas J York, Anthony J Blaszczyk, Matthew R Bauerle, Squire J Booker
{"title":"钴胺依赖的自由基SAM酶激活自由基氟甲基化。","authors":"Syam Sundar Neti, Bo Wang, Jiayuan Cui, David F Iwig, Nicholas J York, Anthony J Blaszczyk, Matthew R Bauerle, Squire J Booker","doi":"10.1021/acsbiomedchemau.5c00062","DOIUrl":null,"url":null,"abstract":"<p><p>Fluorine is an important atom in many drugs because it can improve the efficacy and metabolic stability of many molecules. Strategies to incorporate monofluoromethyl groups in drugs have been limited and have received less attention than strategies for difluoromethylation or trifluoromethylation. Previously, we and others reported the enzymatic monofluoromethylation of several biologically relevant metabolites based on the transfer of a fluoromethyl group from analogs of <i>S</i>-adenosylmethionine (SAM) to various nucleophiles (carbon, oxygen, nitrogen, sulfur, and carbon) through a polar S<sub>N</sub>2 mechanism. However, this strategy is limited to molecules containing nucleophilic target atoms. Inspired by a subset of enzymes within the radical SAM superfamily that can methylate inert carbon atoms, we developed an enzymatic strategy to transfer fluoromethyl groups to unactivated carbon atoms. This strategy leverages the ability of halide methyltransferase to generate a transient fluoromethyl-containing SAM analog. Our studies show that <i>S</i>-adenosyl-<i>L</i>-(fluoromethyl)-methionine can undergo reductive cleavage to a 5'-deoxyadenosyl 5'-radical, which initiates radical-dependent fluoromethylation through substrate hydrogen-atom abstraction. Adding fluoromethyl groups to unactivated C-H bonds using radical SAM enzymes is a powerful approach that can be used to derivatize molecules of interest where S<sub>N</sub>2-based fluoromethylation is precluded.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 3","pages":"464-474"},"PeriodicalIF":3.8000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12183590/pdf/","citationCount":"0","resultStr":"{\"title\":\"Radical Fluoromethylation Enabled by Cobalamin-Dependent Radical SAM Enzymes.\",\"authors\":\"Syam Sundar Neti, Bo Wang, Jiayuan Cui, David F Iwig, Nicholas J York, Anthony J Blaszczyk, Matthew R Bauerle, Squire J Booker\",\"doi\":\"10.1021/acsbiomedchemau.5c00062\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Fluorine is an important atom in many drugs because it can improve the efficacy and metabolic stability of many molecules. Strategies to incorporate monofluoromethyl groups in drugs have been limited and have received less attention than strategies for difluoromethylation or trifluoromethylation. Previously, we and others reported the enzymatic monofluoromethylation of several biologically relevant metabolites based on the transfer of a fluoromethyl group from analogs of <i>S</i>-adenosylmethionine (SAM) to various nucleophiles (carbon, oxygen, nitrogen, sulfur, and carbon) through a polar S<sub>N</sub>2 mechanism. However, this strategy is limited to molecules containing nucleophilic target atoms. Inspired by a subset of enzymes within the radical SAM superfamily that can methylate inert carbon atoms, we developed an enzymatic strategy to transfer fluoromethyl groups to unactivated carbon atoms. This strategy leverages the ability of halide methyltransferase to generate a transient fluoromethyl-containing SAM analog. Our studies show that <i>S</i>-adenosyl-<i>L</i>-(fluoromethyl)-methionine can undergo reductive cleavage to a 5'-deoxyadenosyl 5'-radical, which initiates radical-dependent fluoromethylation through substrate hydrogen-atom abstraction. Adding fluoromethyl groups to unactivated C-H bonds using radical SAM enzymes is a powerful approach that can be used to derivatize molecules of interest where S<sub>N</sub>2-based fluoromethylation is precluded.</p>\",\"PeriodicalId\":29802,\"journal\":{\"name\":\"ACS Bio & Med Chem Au\",\"volume\":\"5 3\",\"pages\":\"464-474\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12183590/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Bio & Med Chem Au\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1021/acsbiomedchemau.5c00062\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/18 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Bio & Med Chem Au","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1021/acsbiomedchemau.5c00062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/18 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Radical Fluoromethylation Enabled by Cobalamin-Dependent Radical SAM Enzymes.
Fluorine is an important atom in many drugs because it can improve the efficacy and metabolic stability of many molecules. Strategies to incorporate monofluoromethyl groups in drugs have been limited and have received less attention than strategies for difluoromethylation or trifluoromethylation. Previously, we and others reported the enzymatic monofluoromethylation of several biologically relevant metabolites based on the transfer of a fluoromethyl group from analogs of S-adenosylmethionine (SAM) to various nucleophiles (carbon, oxygen, nitrogen, sulfur, and carbon) through a polar SN2 mechanism. However, this strategy is limited to molecules containing nucleophilic target atoms. Inspired by a subset of enzymes within the radical SAM superfamily that can methylate inert carbon atoms, we developed an enzymatic strategy to transfer fluoromethyl groups to unactivated carbon atoms. This strategy leverages the ability of halide methyltransferase to generate a transient fluoromethyl-containing SAM analog. Our studies show that S-adenosyl-L-(fluoromethyl)-methionine can undergo reductive cleavage to a 5'-deoxyadenosyl 5'-radical, which initiates radical-dependent fluoromethylation through substrate hydrogen-atom abstraction. Adding fluoromethyl groups to unactivated C-H bonds using radical SAM enzymes is a powerful approach that can be used to derivatize molecules of interest where SN2-based fluoromethylation is precluded.
期刊介绍:
ACS Bio & Med Chem Au is a broad scope open access journal which publishes short letters comprehensive articles reviews and perspectives in all aspects of biological and medicinal chemistry. Studies providing fundamental insights or describing novel syntheses as well as clinical or other applications-based work are welcomed.This broad scope includes experimental and theoretical studies on the chemical physical mechanistic and/or structural basis of biological or cell function in all domains of life. It encompasses the fields of chemical biology synthetic biology disease biology cell biology agriculture and food natural products research nucleic acid biology neuroscience structural biology and biophysics.The journal publishes studies that pertain to a broad range of medicinal chemistry including compound design and optimization biological evaluation molecular mechanistic understanding of drug delivery and drug delivery systems imaging agents and pharmacology and translational science of both small and large bioactive molecules. Novel computational cheminformatics and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules ligands and their targets are also welcome. The journal will consider computational studies applying established computational methods but only in combination with novel and original experimental data (e.g. in cases where new compounds have been designed and tested).Also included in the scope of the journal are articles relating to infectious diseases research on pathogens host-pathogen interactions therapeutics diagnostics vaccines drug-delivery systems and other biomedical technology development pertaining to infectious diseases.